According to BioLineRx's latest financial reports the company's current EPS (TTM) is -$0.90. In 2022 the company made an earnings per share (EPS) of -$0.45 an increase over its 2021 EPS that were of -$0.60.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.90 | 100% |
2022 | -$0.45 | -25% |
2021 | -$0.60 | -66.67% |
2020 | -$1.80 | -29.41% |
2019 | -$2.55 | -19.05% |
2018 | -$3.15 | -22.22% |
2017 | -$4.05 | -3.57% |
2016 | -$4.20 | -0% |
2015 | -$4.20 | -17.65% |
2014 | -$5.10 | -55.26% |
2013 | -$11.40 | -36.9% |
2012 | -$18.07 | 11.81% |
2011 | -$16.16 | -737.01% |
2010 | $2.54 |